`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`ADAMIS PHARMACEUTICALS CORPORATION
`Petitioner
`
`v.
`
`BELCHER PHARMACEUTICALS, LLC
`Patent Owner
`
`_____________________
`CASE: IPR2019-01021
`U.S. PATENT NO. 9,283,197
`_____________________
`
`
`JOINT MOTION TO TERMINATE PURSUANT TO 35 U.S.C. § 317(b)
`AND 37 C.F.R. § 42.74(c)
`
`
`
`
`
`
`
`
`
`
`
`I.
`
`
`PRECISE RELIEF REQUESTED
`
`Pursuant to 35 U.S.C. § 317(a), Petitioner Adamis Pharmaceuticals
`
`Corporation, LLC (“Petitioner”) and Patent Owner Belcher Pharmaceuticals, LLC
`
`(“Patent Owner”) jointly request termination of the inter partes review of U.S. Patent
`
`No. 9,283,197 (“the ’197 patent”), Case IPR2019-01021, based on a settlement and
`
`license agreement between Petitioner and Patent Owner.
`
`II. REASONS FOR GRANTING THE MOTION
`
`
`
`Pursuant to 35 U.S.C. § 317(a) and 37 C.F.R. § 42.72, an inter partes review
`
`proceeding “shall be terminated with respect to any petitioner upon the joint request
`
`of the petitioner and the patent owner, unless the Office has decided the merits of
`
`the proceeding before the request for termination is filed.”
`
`The Board authorized the filing of the instant joint motion and request in its
`
`e-mail to the parties on July 26, 2019. Consistent with the Board’s standing practice,
`
`the Board’s notice of authorization instructs the parties that their joint motion should:
`
`(1) include a brief explanation as to why termination is appropriate; (2) identify all
`
`parties in any related district court litigation involving the patents in dispute and
`
`discuss the current status of each such related litigation with respect to each party to
`
`the litigation, and (3) identify the case numbers of any pending, related inter partes
`
`review proceedings. This motion satisfies each of the above requirements and is
`
`
`
`
`
`
`
`also accompanied by a true copy of the Parties’ fully-executed settlement and license
`
`agreement, as required by 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(b).
`
`
`
`1.
`
`Termination is Appropriate
`
`
`
`Termination is appropriate because the Parties have settled their dispute and
`
`this inter partes review has not been instituted. Petitioner filed its petition for inter
`
`partes review on April 26, 2019. Patent Owner has not filed a preliminary response.
`
`The Parties have settled their dispute, and have reached agreement to terminate this
`
`inter partes review proceeding.
`
`2.
`
`All Parties in any Pending Related Litigation Involving the
`Patent at Issue and the Current Status of each Related
`Litigation with Respect to each Party to the Litigation
`Petitioner filed an action for a declaratory judgment of non-infringement
`
`against the ’197 Patent in the Middle District of Florida Case No. 8:18-cv-02379-
`
`WFJ-AAS. On July 25, 2019, Petitioner filed an Unopposed Stipulation to Dismiss
`
`with Prejudice Case No. 8:18-cv-02379. On July 29, 2019, the District Court
`
`dismissed the case with prejudice.
`
`
`
`Patent Owner is presently asserting the ‘197 Patent against International
`
`Medication System Limited and Hospira, Inc. in the District of Delaware, Case Nos.
`
`1-18-cv-00960 and 1-17-cv-00775, respectively. A bench trial was held in Case No.
`
`1-17-cv-00775 against Hospira, Inc. on June 19 and 20, 2019. The court has not yet
`
`
`
`
`
`
`
`issued its ruling following the bench trial. Case No. 1-18-cv-00960 against
`
`International Medication System Limited is currently stayed pending the outcome
`
`of Case No. 1-17-cv-00775.
`
`3.
`Related Inter Partes Review Proceedings
`Aside from this inter partes review proceeding, the ‘197 Patent is not involved
`
`in any pending, related post grant review proceedings, or any other proceeding
`
`currently before the Patent Office.
`
`
`III. SETTLEMENT AGREEMENT
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(b), the Parties’
`
`Settlement Agreement has been made in writing, and a true and correct copy is being
`
`filed concurrently herewith as Exhibit 1026.1
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), and the Board’s
`
`authorization of the filing of this joint request in its email to the Parties on July 26,
`
`2019, the Parties jointly request that the true copy of the Settlement Agreement filed
`
`concurrently herewith as Exhibit 1026 be treated as business confidential
`
`information, which shall be kept separate from the file of U.S. Patent No. 9,283,197.
`
`
`1 The Settlement Agreement is being filed via the Patent Review Processing
`System (PRPS) with access to “Parties and Board Only.”
`
`
`
`
`
`
`
`The Parties further request the Board to not make Exhibit 1026 available to any third
`
`party, except as provided for in 35 U.S.C. § 327(b) and 37 C.F.R. § 42.74(c).
`
`IV. CONCLUSION
`
`For all of these reasons, Petitioner and Patent Owner respectfully request
`
`termination of the inter partes review of U.S. Patent No. 9,283,197, Case IPR2019-
`
`01021.
`
`
`Dated: July 29, 2019
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Jason A. Engel/
`Jason A. Engel
`Reg. No. 51,654
`Customer No. 24573
`Jason.Engel.PTAB@klgates.com
`T: (312) 807-4236
`F: (312) 827-8145
`K&L Gates LLP
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`Counsel for Petitioner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
` hereby certify that a true and correct copy of the foregoing, JOINT MOTION TO
`
` I
`
`TERMINATE PURSUANT TO 35 U.S.C. § 317(b) AND 37 C.F.R. § 42.74(c)
`
`were served on July 29, 2019 via electronic mail on the following counsel of record
`
`for Patent Owner:
`
`
`Cole Y. Carlson
`cole.carlson@gray-robinson.com
`Stefan V. Stein
`stefan.stein@gray-robinson.com
`ptotpa@gray-robinson.com
`GrayRobinson, P.A.
`401 E. Jackson Street, Suite 2700
`Tampa, FL 33602
`Telephone: (813) 273-5000
`
`
`
`
`
`
`
`
`
`
`
`By:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Jason A. Engel/
`Jason A. Engel
`Reg. No. 51,654
`Customer No. 24573
`Jason.Engel.PTAB@klgates.com
`T: (312) 807-4236
`F: (312) 827-8145
`K&L Gates LLP
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`
`